Halfway to goal!

End point doc picked. Halfway lowest weight height, highest still normal range. Smart, pounds play either goal. Twenty to go. There stay year then maintenance.
 
Would be amazing dropping 30kg in 6 months to halfway there. Got nothing but severe illness instead and had to pause twice along with Ozempic.
 
IGF-1 tracking can give you decent feedback on whether your dose is actually working right. I've been meaning to get baseline labs done before jumping in but haven't gotten around to it yet. Testing at the midpoint might help you adjust faster rather than waiting till the end to see how it went.
 
Novo Nordisk's patent expires soon in countries that are home to 40 percent of the world's population. Generic versions could arrive in India soon and more to come. Prices will drop massively—the drug's been out of reach for almost everyone except the wealthiest till now.
 
Fitting in a seat without a belt extender is one of those milestones that people think about but rarely say out loud. 60 pounds covers most people and leaves some margin.
 
The no-calorie-tracking approach is sustainable in a way that counting often is not. The medication shifts the food relationship in a way that makes internal signals more reliable. Building around those signals rather than a number is the right framing for lasting change. 310 to 250 with 50 more to go proves the approach works.
 
Planning supply at the actuarial scale is a serious commitment. 9 years at therapeutic dose means the cost structure matters as much as the clinical response. Most reach that view after the medication proves itself.
 
Halfway at 60 lbs down from 310 is the stage where the metabolic foundation is already set. The remaining stretch moves slower but the body's cooperation is more reliable than it was in the beginning.
 
You must log in or register to reply here.
Back
Top